(Q35095094)

English

Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Change in psychosocial functioning and quality of life of patients with body dysmorphic disorder treated with fluoxetine: a placebo-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

0 references

body dysmorphic disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Katharine A Phillips

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven A Rasmussen

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

438-444

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A review of cognitive and behavioral treatment for body dysmorphic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Axis I comorbidity in body dysmorphic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

An open-label study of citalopram in body dysmorphic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Effectiveness research and implications for study design: sample size and statistical power

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Body dysmorphic disorder: the distress of imagined ugliness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

9 July 2018

Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

27 September 2018

Quality of life for patients with body dysmorphic disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

27 September 2018

SF-36 summary scores: are physical and mental health truly distinct?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

27 September 2018

Gender differences in body dysmorphic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

27 September 2018

Suicide in dermatological patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1613753

27 September 2018

The Modified Hamilton Rating Scale for Depression: reliability and validity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dermatological non-disease: a common and potentially fatal disturbance of cutaneous body image

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of the longitudinal interval follow-up evaluation for assessing outcome of anxiety disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body Dysmorphic Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body dysmorphic disorder: 30 cases of imagined ugliness

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The functioning and well-being of depressed patients. Results from the Medical Outcomes Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale

1 reference

https://pubmed.ncbi.nlm.nih.gov/15345790

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1176/APPI.PSY.45.5.438

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35095094&oldid=1569167973"